312 related articles for article (PubMed ID: 15885882)
1. DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma.
Park HJ; Yu E; Shim YH
Cancer Lett; 2006 Feb; 233(2):271-8. PubMed ID: 15885882
[TBL] [Abstract][Full Text] [Related]
2. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
[TBL] [Abstract][Full Text] [Related]
3. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis.
Saito Y; Kanai Y; Sakamoto M; Saito H; Ishii H; Hirohashi S
Hepatology; 2001 Mar; 33(3):561-8. PubMed ID: 11230735
[TBL] [Abstract][Full Text] [Related]
4. DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis.
Kanai Y; Hui AM; Sun L; Ushijima S; Sakamoto M; Tsuda H; Hirohashi S
Hepatology; 1999 Mar; 29(3):703-9. PubMed ID: 10051471
[TBL] [Abstract][Full Text] [Related]
5. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI
Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
[TBL] [Abstract][Full Text] [Related]
6. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
7. Expression of DNA methyltransferases in multistep hepatocarcinogenesis.
Choi MS; Shim YH; Hwa JY; Lee SK; Ro JY; Kim JS; Yu E
Hum Pathol; 2003 Jan; 34(1):11-7. PubMed ID: 12605361
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells.
Ahluwalia A; Hurteau JA; Bigsby RM; Nephew KP
Gynecol Oncol; 2001 Aug; 82(2):299-304. PubMed ID: 11531283
[TBL] [Abstract][Full Text] [Related]
9. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
Girault I; Tozlu S; Lidereau R; Bièche I
Clin Cancer Res; 2003 Oct; 9(12):4415-22. PubMed ID: 14555514
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis.
Zhu YZ; Zhu R; Shi LG; Mao Y; Zheng GJ; Chen Q; Zhu HG
Exp Mol Pathol; 2010 Dec; 89(3):268-75. PubMed ID: 20620135
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity.
Yakushiji T; Uzawa K; Shibahara T; Noma H; Tanzawa H
Int J Oncol; 2003 Jun; 22(6):1201-7. PubMed ID: 12738984
[TBL] [Abstract][Full Text] [Related]
12. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
13. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
[TBL] [Abstract][Full Text] [Related]
14. Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer.
Kim H; Kwon YM; Kim JS; Han J; Shim YM; Park J; Kim DH
Cancer; 2006 Sep; 107(5):1042-9. PubMed ID: 16888795
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis.
Saito Y; Kanai Y; Sakamoto M; Saito H; Ishii H; Hirohashi S
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10060-5. PubMed ID: 12110732
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide hypomethylation in hepatocellular carcinogenesis.
Lin CH; Hsieh SY; Sheen IS; Lee WC; Chen TC; Shyu WC; Liaw YF
Cancer Res; 2001 May; 61(10):4238-43. PubMed ID: 11358850
[TBL] [Abstract][Full Text] [Related]
17. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan.
Hsu LS; Lee HC; Chau GY; Yin PH; Chi CW; Lui WY
Oncol Rep; 2006 Feb; 15(2):507-11. PubMed ID: 16391877
[TBL] [Abstract][Full Text] [Related]
19. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma.
Li X; Hui AM; Sun L; Hasegawa K; Torzilli G; Minagawa M; Takayama T; Makuuchi M
Clin Cancer Res; 2004 Nov; 10(22):7484-9. PubMed ID: 15569978
[TBL] [Abstract][Full Text] [Related]
20. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
Zhang C; Li Z; Cheng Y; Jia F; Li R; Wu M; Li K; Wei L
Clin Cancer Res; 2007 Feb; 13(3):944-52. PubMed ID: 17289889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
